CN Stock MarketDetailed Quotes

300630 Hainan Poly Pharm

Watchlist
  • 17.83
  • -0.16-0.89%
Market Closed Mar 29 15:00 CST
8.06BMarket Cap21.80P/E (TTM)

About Hainan Poly Pharm Company

The company (stock code: 300630) was founded in 1992 to open up the entire pharmaceutical manufacturing industry chain and form the integration of key intermediates, APIs and formulations. Based on pharmaceutical production quality management standards such as the US FDA, EU EMA, WHO, and China NMPA, etc., the company continues to improve pharmaceutical production process levels and quality control capabilities, intelligent pharmaceutical manufacturing and automated production capabilities, and build production bases for APIs, solid preparations and injections with a high quality management level. The company is a high-tech enterprise specializing in drug research and development, registration, production and sales. The products sold by the company are mainly prescription drugs, covering anti-allergic drugs, non-steroidal analgesic and anti-inflammatory drugs, antibiotics, digestive drugs, etc., cardiovascular drugs, contrast agents, first-aid drugs, etc. field. Company honors: The “Development and production transformation of sodium diclofenac enteric sustained-release capsules” project won the second prize of science and technology in Hainan Province, the “development and industrialization of desloratadine dry suspensions” project won the third prize of science and technology in Hainan Province, “Fubiding (desloratadine dry suspension)” was rated as an excellent product in the pharmaceutical industry in Hainan Province by the Hainan Pharmaceutical Industry Association. Desloratadine dispersion tablets and desloratadine dry pharmaceutical suspensions won the Chinese brand at the “28th National Pharmaceutical Economic Information Conference” · 2016 Hospital terminal and primary terminal brand list (anti-allergic drug category), pharmaceutical industry 13th Five-Year “Enterprise Management Award”.

Company Profile

Short Name-A普利制药
Symbol-A300630
Company NameHainan Poly Pharm Co, Ltd
Listing Date03/28/2017
Issue Price11.49
Shares Offered30.53M share
Founded07/14/1992
Legal RepresentativeMinhua Fan
General ManagerMinhua Fan
SecretaryMao Zhou
Accounting FirmTianjian Certified Public Accountants (Special General Partnership)
Legal CounselBeijing Deheng Law Firm
Employees1488
Number0898-66661090
Office AddressGuilinyang Economic Development Zone, Meilan District, Haikou City, Hainan Province
Zip Code571127
Registered AddressGuilinyang Economic Development Zone, Meilan District, Haikou City, Hainan Province
Fax0898-65710298
Emailsecurities@hnpoly.com
Business License460000000140801
BusinessSet up factories, research and development, production and sales of Western medicine APIs, intermediates and preparations, proprietary Chinese medicines, and pharmaceutical information services.

Company Executives

  • Name
  • Position
  • Salary
  • Minhua Fan
  • Chairman,Director,GM
  • 765.60K
  • Iao shuge(jiaoshuge) J
  • Director
  • --
  • Mao Zhou
  • Director,Company Secretary,Deputy GM
  • 592.80K
  • Tongning Luo
  • Director,Deputy GM,Finance Director
  • 579.10K
  • Dezhu Fan
  • Independent Director
  • 60.00K
  • Lei Pan
  • Independent Director,Audit Committee Member
  • 60.00K
  • Yadong Chen
  • Independent Director
  • 60.00K
  • Yu Ding
  • Chairman of the Supervisory Board,Supervisor
  • 288.90K
  • Jiping Wang
  • Supervisor,Enterprise Management Manager
  • 232.90K
  • Yinkui Zou
  • Deputy GM
  • 572.70K
  • Xuelai Zhou
  • Deputy GM
  • 592.70K
  • Huifang Xie
  • Deputy HR Manager,Employee Representative Supervisor
  • 263.50K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
%Chg